Related Experiment Video
Updated: May 25, 2026

09:35
Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain
Published on: May 10, 2017
Triangular stimulation method utilizing combination spinal cord stimulation with peripheral subcutaneous field
Rosa M Navarro1, Danika C Vercimak
1Memorial Hospital of South Bend, Pain Control Center, South Bend, Indiana, USA. navarro_pain_gru@me.com
Neuromodulation : Journal of the International Neuromodulation Society
|February 15, 2012
Summary
Combination spinal cord stimulation (SCS) and peripheral subcutaneous field stimulation (PSFS) offers potential pain relief and reduced medication for chronic pain patients. Further prospective studies are needed to confirm long-term efficacy.
Area of Science:
- Neurology
- Pain Management
- Biomedical Engineering
Background:
- Chronic intractable pain affects millions, often inadequately managed by conventional treatments.
- Neuromodulation offers alternative therapeutic strategies for refractory pain conditions.
- Spinal cord stimulation (SCS) and peripheral subcutaneous field stimulation (PSFS) are emerging techniques.
Purpose of the Study:
- To evaluate the efficacy of combined SCS and PSFS in patients with chronic intractable pain.
- To assess short- and long-term pain reduction and medication use following combined SCS/PSFS implantation.
- To analyze device usage patterns and patient-preferred stimulation parameters.
Main Methods:
- Retrospective data analysis of 40 patients with chronic pain receiving combined SCS and PSFS.
- Comparison of pre-implant and post-implant pain levels, medication usage, and device parameters.
- Follow-up period of approximately six months to assess pain management outcomes.
Main Results:
- A majority of patients experienced immediate and short-term pain relief and decreased oral pain medication use.
- Pain improvement was sustained in some patients at six months, but not all.
- Triangular stimulation emerged as a consistently preferred program, particularly for low back pain.
Conclusions:
- Combined SCS and PSFS therapy shows potential as a beneficial treatment for chronic pain, reducing pain and medication reliance.
- Further investigation in larger, prospective, controlled studies is warranted.
- Subcutaneous field stimulation requires further research and regulatory pathways for broader clinical adoption.

